Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Ding, Yahui  [Clear All Filters]
2015
Gao Y, Yang P, Shen H, Yu H, Song X, Zhang L, Zhang P, Cheng H, Xie Z, Hao S, et al. Small-molecule inhibitors targeting INK4 protein p18(INK4C) enhance ex vivo expansion of haematopoietic stem cells. Nat Commun. 2015;6:6328.
2016
Zhang Y, Xie X-QSean, Wang L, Cheng H, McGuire TFrancis, Ding Y, Feng Z, Cheng T, Gao Y. StemCellCKB: An Integrated Stem Cell-Specific Chemogenomics Knowledge Base for Target Identification and Systems-Pharmacology Research. J Chem Inf Model. 2016.
Si X, Zhang X, Hao X, Li Y, Chen Z, Ding Y, Shi H, Bai J, Gao Y, Cheng T, et al. Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion. Oncotarget. 2016.
2019
Xiang J, Ding Y, Li J, Zhao X, Sun Y, Wang D, Wang L, Chen Y. Ovatodiolides: Scalable Protection-free Syntheses, Configuration Determination and Biological Evaluation against Hepatic Cancer Stem Cells. Angew Chem Int Ed Engl. 2019.
Ding Y, Pan W, Xu J, Wang T, Chen T, Liu Z, Xie C, Zhang Q. Sesquiterpenoids from the roots of Inula helenium inhibit acute myelogenous leukemia progenitor cells. Bioorg Chem. 2019;86:363-367.
2020
Li Y, Gu J, Ding Y, Gao H, Li Y, Sun Y, He M, Zhang W, Yin J, Bai C, et al. A small molecule compound IX inhibits telomere and attenuates oncogenesis of drug-resistant leukemia cells. FASEB J. 2020.
2023
Deng H, Liu H, Yang G, Wang D, Luo Y, Li C, Qi Z, Liu Z, Wang P, Jia Y, et al. ACT001 inhibited CD133 transcription by targeting and inducing Olig2 ubiquitination degradation. Oncogenesis. 2023;12(1):19.